Mesoblast Ltd (ASX:MSB)
Pharmaceuticals, Biotechnology & Life Sciences
share price: (EoD)
earnings per share:
dividends per share:
Mesoblast Ltd (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.
Mesoblast Ltd (ASX:MSB) share price
Mesoblast Ltd (ASX:MSB) passive income
Mesoblast Ltd (ASX:MSB) share price news
Today's ASX news
S&P/ASX 200 Pre-Market News
Here are the headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and Australian finance circles on Wednesday morning, with the USA’s Federal Reserve signalling higher rates to come.
July 17, 2018
ASX Share Ideas
Atlassian Corporation’s (TEAM) NASDAQ Listing Helped It Become A Global Success
There is no doubt that Atlassian Corporation PLC (NASDAQ:TEAM), Australia’s darling IT company, is now a global success.
July 17, 2018
